433 Central Ave., 4th Floor, St. Petersburg, FL 33701 | info@poseidon-us.com | Office: (813) 563-2652
“What they found was that of all new drugs approved in the last 20 years, 12% came from the SBIR/STTR program,” said Jere Glover. The post Is it time to reauthorize the Small Business Innovation Research Program? first appeared on Federal News Network.
http://news.poseidon-us.com/TPFkDY

More Posts